Medscape Oncology

🩸 When rare hematologic conditions challenge the usual playbook, be ready. Decode atypical presentations, 🧬 explore novel targeted therapies & sharpen diagnostic and treatment strategies 🎯 Build confidence for complex cases—secure your spot today! mdsc.pe/46oDsAC #ASH26

🩸 From molecular profiling to treatment selection, MDS care continues to evolve! Explore emerging clinical evidence and strategies for managing treatment complexities across the disease continuum. 🎯 Advance your expertise! mdsc.pe/47pCQv9

🔬 How can you optimize care for patients with newly diagnosed multiple myeloma ? Explore clinical evidence for transplant-eligible and ineligible patients, personalized treatment strategies, and the importance of collaborative care. 💡 Strengthen your clinical decision-making—join this educational activity! mdsc.pe/3U0ktts #ASH26

🔍 MDS treatment decisions are becoming increasingly precise. Discover how cytogenetic and molecular characteristics can guide care, examine trial data 🧪 across the disease continuum & strengthen team-based management of treatment complexities. ⚡ Turn evolving evidence into action—join us! mdsc.pe/4r4FVcQ #ASH26

🧬 Choosing the right TKI in CML starts with the right data. Explore first-line selection, navigate resistance & translate mutational analysis into therapeutic decisions with coordinated team-based care. 🎯 Sharpen your CML strategy—register today! mdsc.pe/4zRXX6p #ASH26

💡 How can clinicians translate advances in immuno-oncology into better treatment decisions? Explore antigen-directed therapies, biomarker-driven selection & practical strategies for individualized cancer care. 🔬 📢 Stay ahead of emerging evidence—explore this educational activity today! 🔗 mdsc.pe/4sImjMH

🦟 Stay current on dengue prevention! Explore the latest data, strengthen vaccine 💉recommendations, and gain confidence addressing patient questions and concerns about dengue vaccination. 🌎 Click here now: mdsc.pe/4ARfGLF

Spotlight on NTRK Fusions: Clinical Care Insights Across Lung and Thyroid Cancer xitter.gq/i/broadcasts/2lgyKAqvq…

Starting in 1 HOUR ➡️ mdsc.pe/4k9208O Gain expert insights on NTRK fusions in lung and thyroid cancer. Join LIVE! 🗓️ Today ⏰ 12:00pm EST #Oncology #NTRKFusions #MedEd

🧬 MASH care is moving beyond liver-only thinking. Explore the MASLD-to-MASH spectrum, cardiometabolic risk, emerging therapies, noninvasive risk assessment, and phenotype-driven treatment strategies. 📊 Advance your approach—register today! mdsc.pe/3U4CNS7

PBC treatment checkpoint: 🛑➡️🟢 First-line response falling short? Explore when to advance therapy, how to select second-line options, and 🧬 how to build management around what matters to the patient. 💬 Ready for the next step? Join us! mdsc.pe/4iRKdlN

Oral SERDs bring new possibilities for patients with early breast cancer. By integrating emerging evidence with clinical experience, we can drive meaningful progress in treatment strategies. mdsc.pe/4z5AwF8

🧪 Systemic mastocytosis care is evolving across the disease spectrum. Explore recent clinical trial data, identify patients who may benefit from advanced treatment & ✨ evaluate whether disease control is truly adequate. 🧭 Stay ahead of SM care—register today! mdsc.pe/4yhO28u #ASH26

🧬 What's new in sickle cell disease (SCD) care? Explore gene therapies, emerging PK activators, and personalized treatment strategies. 🔍 Expand your clinical knowledge—join this educational activity! mdsc.pe/4zpr7Zo #ASH26

💙 Living with systemic mastocytosis? Join our Community Exchange in Rosemont, IL! 🤝 Connect with SM experts, patients & caregivers, share experiences, and learn how to advocate for better care. 🍽️ Dinner provided. Space is limited—register now! mdsc.pe/4z6jAyI

LIVE TOMORROW ➡️ mdsc.pe/4k9208O Equip your practice with actionable insights on NTRK fusions in lung and thyroid cancer. 🗓️ November 6th ⏰ 12:00pm EST #Oncology #NTRKFusions #MedEd

🔄 Sequence matters in HER2-positive GEA. Dive into emerging anti-HER2 evidence, navigate treatment decisions across the patient journey & strengthen strategies for managing diarrhea and optimizing safety. 🤝 Advance your GEA approach—save your spot! mdsc.pe/4hk4FcR

How do you define refractory HSV when standard antivirals fail? Dr. Princy Kumar, Dr. Anna Wald, and Dr. Edoabasi McGee discuss key diagnostic clues and emerging oral therapies. Watch the full discussion ➡️ mdsc.pe/4A89e1B #InfectiousDisease #CME #MedEd

🧭 From diagnosis to coordinated care in adult PFIC & ALGS. Explore the multisystem nature of these genetic cholestatic liver diseases, identify where targeted therapies fit & build effective interprofessional care models. 🔬 Expand your expertise—join us! mdsc.pe/4h8ewDH

👉 Sharpen your approach to AL amyloidosis! 💬 Differentiate amyloid disorders, interpret treatment data, personalize therapy, and strengthen coordinated workflows to support timely, effective care. mdsc.pe/4x5jqGX #ASH26